- Home
- ONFO vs PRFX Comparison
ONFO vs PRFX Comparison
Compare ONFO & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONFO | PRFX |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 2.7M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ONFO | PRFX |
|---|---|---|
| Price | $0.73 | $1.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 67.3K | ★ 3.5M |
| Earning Date | 11-17-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,238,989.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 70.54 | N/A |
| 52 Week Low | $0.59 | $0.61 |
| 52 Week High | $1.95 | $6.65 |
Technical Indicators
Market Signals| Indicator | ONFO | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 44.54 | 68.03 |
| Support Level | $0.70 | $0.77 |
| Resistance Level | $0.85 | $0.92 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 52.31 | 55.06 |
Price Performance
Historical ComparisonAbout ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.